CALX

SEC source: 0001406666-25-000031 · wk-form4_1751402744.xml · derivative · entry 3

SINDELAR CORY · CIK 0001226868 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 265,000

Underlying: Common Stock · 10,000 shares

Expires 2027-10-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: 100% of the shares subject to the option were fully vested and exercisable on October 1, 2021.

SEC source: 0001406666-25-000031 · wk-form4_1751402744.xml · nonDerivative · entry 2

SINDELAR CORY · CIK 0001226868 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 76,285

SEC source: 0001406666-25-000031 · wk-form4_1751402744.xml · nonDerivative · entry 1

SINDELAR CORY · CIK 0001226868 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 86,285

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001483757-25-000004 · wk-form4_1752699245.xml · derivative · entry 1

Russo Carl · CIK 0001483757 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,561

Underlying: Common Stock · 11,561 shares

Expires 2035-06-30

F1 · derivative.exercise_date: The automatically awarded option vests and becomes exercisable with respect to 25% of the shares of common stock underlying the option on each anniversary of the date of grant (June 30, 2025).

SEC source: 0001406666-25-000030 · wk-form4_1748982296.xml · derivative · entry 5

Weening Michael · CIK 0001678385 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 184,000

Underlying: Common Stock · 20,000 shares

Expires 2027-12-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: 100% of the shares subject to the option were fully vested and exercisable on January 1, 2021.

SEC source: 0001406666-25-000030 · wk-form4_1748982296.xml · derivative · entry 4

Weening Michael · CIK 0001678385 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 80,000 shares

Expires 2026-06-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: 100% of the shares subject to the option were fully vested and exercisable on June 27, 2020.

SEC source: 0001406666-25-000030 · wk-form4_1748982296.xml · nonDerivative · entry 3

Weening Michael · CIK 0001678385 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,812

F1 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $46.025 to $47.005, inclusive. Full information on the number of shares sold at each sale price is available upon request.

SEC source: 0001406666-25-000030 · wk-form4_1748982296.xml · nonDerivative · entry 2

Weening Michael · CIK 0001678385 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 115,812

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001406666-25-000030 · wk-form4_1748982296.xml · nonDerivative · entry 1

Weening Michael · CIK 0001678385 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 95,812

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001406666-25-000020 · wk-form4_1747080364.xml · derivative · entry 4

Russo Carl · CIK 0001483757 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,606

Underlying: Common Stock · 28,606 shares

Expires 2035-05-08

F4 · derivative.exercise_date: The option vests and becomes exercisable with respect to 25% of the shares of common stock underlying the option on each anniversary of the date of grant (May 8, 2025).

SEC source: 0001406666-25-000020 · wk-form4_1747080364.xml · nonDerivative · entry 1

Russo Carl · CIK 0001483757 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,753,070

F1 · shares: Represents an award of restricted stock pursuant to the Issuer non-employee director equity compensation policy, which will vest on the day immediately preceding the date of the annual meeting of stockholders that occurs in the year following the year of grant.

SEC source: 0001406666-25-000027 · wk-form4_1747080768.xml · nonDerivative · entry 1

BERRY MICHAEL J · CIK 0001269088 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,689

F1 · shares: Represents an award of restricted stock pursuant to the Issuer non-employee director equity compensation policy, which will vest on the day immediately preceding the date of the annual meeting of stockholders that occurs in the year following the year of grant.

SEC source: 0001406666-25-000026 · wk-form4_1747080720.xml · nonDerivative · entry 1

CRUSCO KATHLEEN M · CIK 0001237508 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,394

F1 · shares: Represents an award of restricted stock pursuant to the Issuer non-employee director equity compensation policy, which will vest on the day immediately preceding the date of the annual meeting of stockholders that occurs in the year following the year of grant.

SEC source: 0001406666-25-000024 · wk-form4_1747080569.xml · nonDerivative · entry 1

Mukherjee Rajatish · CIK 0001942773 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,689

F1 · shares: Represents an award of restricted stock pursuant to the Issuer non-employee director equity compensation policy, which will vest on the day immediately preceding the date of the annual meeting of stockholders that occurs in the year following the year of grant.

SEC source: 0001406666-25-000023 · wk-form4_1747080523.xml · nonDerivative · entry 1

Makagon Kira · CIK 0001586648 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,964

F1 · shares: Represents an award of restricted stock pursuant to the Issuer non-employee director equity compensation policy, which will vest on the day immediately preceding the date of the annual meeting of stockholders that occurs in the year following the year of grant.

SEC source: 0001406666-25-000025 · wk-form4_1747080654.xml · nonDerivative · entry 1

Oosterman Wade · CIK 0001587270 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,189

F1 · shares: Represents an award of restricted stock pursuant to the Issuer non-employee director equity compensation policy, which will vest on the day immediately preceding the date of the annual meeting of stockholders that occurs in the year following the year of grant.

F2 · balance_after: In the Form 3 filed for the Reporting Person on August 12, 2024, the 2,500 shares held by the Reporting Person were mistakenly omitted. The shares currently held by the Reporting Person have been increased by 2,500 shares in this Form 4 to correct this error.

SEC source: 0001406666-25-000021 · wk-form4_1747080414.xml · nonDerivative · entry 1

BOWICK CHRISTOPHER J · CIK 0001198471 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,616

F1 · shares: Represents an award of restricted stock pursuant to the Issuer non-employee director equity compensation policy, which will vest on the day immediately preceding the date of the annual meeting of stockholders that occurs in the year following the year of grant.

SEC source: 0001406666-25-000022 · wk-form4_1747080479.xml · nonDerivative · entry 1

Peters Kevin Robert · CIK 0001622622 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 130,717

F1 · shares: Represents an award of restricted stock pursuant to the Issuer non-employee director equity compensation policy, which will vest on the day immediately preceding the date of the annual meeting of stockholders that occurs in the year following the year of grant.

SEC source: 0001406666-25-000017 · wk-form4_1745964009.xml · nonDerivative · entry 1

Russo Carl · CIK 0001483757 · Director · 10% owner

10b5-1 filing: Plan reported

Ownership: Indirect · See Footnote

Disclosed balance after: 2,139,188

F1 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $39.30 to $39.89, inclusive. Full information on the number of shares sold at each sale price is available upon request.

F2 · ownership.nature: Shares held by The Crescentico Trust, Carl Russo, Trustee.

SEC source: 0001406666-25-000009 · wk-form4_1740780189.xml · nonDerivative · entry 1

Russo Carl · CIK 0001483757 · Director · 10% owner

10b5-1 filing: Plan reported

Ownership: Indirect · See Footnote

Disclosed balance after: 2,164,188

F1 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $37.62 to $38.57, inclusive. Full information on the number of shares sold at each sale price is available upon request.

F2 · ownership.nature: Shares held by The Crescentico Trust, Carl Russo, Trustee.

SEC source: 0001406666-25-000007 · wk-form4_1739914999.xml · nonDerivative · entry 1

Weening Michael · CIK 0001678385 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,812

F1 · shares: The reporting person is voluntarily reporting the acquisition of shares of the issuer's common stock pursuant to the Calix, Inc. Amended and Restated Employee Stock Purchase Plan ("ESPP") for the ESPP purchase period of August 15, 2024 through February 14, 2025. This transaction is exempt under Rule 16b-3(c).

F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on August 15, 2024, the first trading day of the purchase period.

SEC source: 0001406666-25-000006 · wk-form4_1739914862.xml · nonDerivative · entry 1

SINDELAR CORY · CIK 0001226868 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 76,285

F1 · shares: The reporting person is voluntarily reporting the acquisition of shares of the issuer's common stock pursuant to the Calix, Inc. Amended and Restated Employee Stock Purchase Plan ("ESPP") for the ESPP purchase period of August 15, 2024 through February 14, 2025. This transaction is exempt under Rule 16b-3(c).

F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on August 15, 2024, the first trading day of the purchase period.

SEC source: 0001406666-25-000003 · wk-form4_1738703642.xml · derivative · entry 3

Eleniak Shane Todd Marshall · CIK 0001886143 · Chief Product Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 195,000

Underlying: Common Stock · 195,000 shares

Expires 2035-01-31

F3 · derivative.exercise_date: The option vests: (i) as to 25% of the shares of common stock subject to the option, on January 31, 2026; and (ii) as to the remaining 75% of the shares of common stock subject to the option, quarterly in equal installments over 36 months from January 31, 2026, subject to continued employment with Calix through the applicable vesting dates.

SEC source: 0001406666-25-000003 · wk-form4_1738703642.xml · derivative · entry 2

Eleniak Shane Todd Marshall · CIK 0001886143 · Chief Product Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,850

Underlying: Common Stock · 68,850 shares

Expires 2034-02-08

F2 · derivative.exercise_date: On February 8, 2024, the reporting person was granted a performance-based option to purchase 75,000 shares of common stock. On January 31, 2025, the Committee determined that the performance criteria governing 91.8% of the grant had been achieved, resulting in 68,850 shares of common stock remaining subject to the option. The option vests: (i) as to 25% of the shares of common stock subject to the option, on February 8, 2025; and (ii) as to the remaining 75% of the shares of common stock subject to the option, quarterly in equal installments over 36 months from February 8, 2025, subject to continued employment with Calix through the applicable vesting dates.

SEC source: 0001406666-25-000003 · wk-form4_1738703642.xml · derivative · entry 1

Eleniak Shane Todd Marshall · CIK 0001886143 · Chief Product Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 107,775

Underlying: Common Stock · 107,775 shares

Expires 2034-02-08

F1 · derivative.exercise_date: On February 8, 2024, the reporting person was granted a performance-based stock option to purchase 225,000 shares of common stock. On January 31, 2025, the Talent and Compensation Committee (the Committee) of the Board of Directors of Calix, Inc. (Calix) determined that the performance criteria governing 47.9% of the grant had been achieved, resulting in 107,775 shares of common stock remaining subject to the option. The option vests: (i) as to 25% of the shares of common stock subject to the option, on February 8, 2025; and (ii) as to the remaining 75% of the shares of common stock subject to the option, quarterly in equal installments over 36 months from February 8, 2025, subject to continued employment with Calix through the applicable vesting dates.

SEC source: 0001406666-25-000005 · wk-form4_1738703851.xml · derivative · entry 3

Weening Michael · CIK 0001678385 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 217,500

Underlying: Common Stock · 217,500 shares

Expires 2035-01-31

F3 · derivative.exercise_date: The option vests: (i) as to 25% of the shares of common stock subject to the option, on January 31, 2026; and (ii) as to the remaining 75% of the shares of common stock subject to the option, quarterly in equal installments over 36 months from January 31, 2026, subject to continued employment with Calix through the applicable vesting dates.

SEC source: 0001406666-25-000005 · wk-form4_1738703851.xml · derivative · entry 2

Weening Michael · CIK 0001678385 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,325

Underlying: Common Stock · 80,325 shares

Expires 2034-02-08

F2 · derivative.exercise_date: On February 8, 2024, the reporting person was granted a performance-based option to purchase 87,500 shares of common stock. On January 31, 2025, the Committee determined that the performance criteria governing 91.8% of the grant had been achieved, resulting in 80,325 shares of common stock remaining subject to the option. The option vests: (i) as to 25% of the shares of common stock subject to the option, on February 8, 2025; and (ii) as to the remaining 75% of the shares of common stock subject to the option, quarterly in equal installments over 36 months from February 8, 2025, subject to continued employment with Calix through the applicable vesting dates.

SEC source: 0001406666-25-000005 · wk-form4_1738703851.xml · derivative · entry 1

Weening Michael · CIK 0001678385 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 125,737

Underlying: Common Stock · 125,737 shares

Expires 2034-02-08

F1 · derivative.exercise_date: On February 8, 2024, the reporting person was granted a performance-based stock option to purchase 262,500 shares of common stock. On January 31, 2025, the Talent and Compensation Committee (the Committee) of the Board of Directors of Calix, Inc. (Calix) determined that the performance criteria governing 47.9% of the grant had been achieved, resulting in 125,737 shares of common stock remaining subject to the option. The option vests: (i) as to 25% of the shares of common stock subject to the option, on February 8, 2025; and (ii) as to the remaining 75% of the shares of common stock subject to the option, quarterly in equal installments over 36 months from February 8, 2025, subject to continued employment with Calix through the applicable vesting dates.

SEC source: 0001406666-25-000004 · wk-form4_1738703718.xml · derivative · entry 3

SINDELAR CORY · CIK 0001226868 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 170,000

Underlying: Common Stock · 170,000 shares

Expires 2035-01-31

F3 · derivative.exercise_date: The option vests: (i) as to 25% of the shares of common stock subject to the option, on January 31, 2026; and (ii) as to the remaining 75% of the shares of common stock subject to the option, quarterly in equal installments over 36 months from January 31, 2026, subject to continued employment with Calix through the applicable vesting dates.

SEC source: 0001406666-25-000004 · wk-form4_1738703718.xml · derivative · entry 2

SINDELAR CORY · CIK 0001226868 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,850

Underlying: Common Stock · 68,850 shares

Expires 2034-02-08

F2 · derivative.exercise_date: On February 8, 2024, the reporting person was granted a performance-based option to purchase 75,000 shares of common stock. On January 31, 2025, the Committee determined that the performance criteria governing 91.8% of the grant had been achieved, resulting in 68,850 shares of common stock remaining subject to the option. The option vests: (i) as to 25% of the shares of common stock subject to the option, on February 8, 2025; and (ii) as to the remaining 75% of the shares of common stock subject to the option, quarterly in equal installments over 36 months from February 8, 2025, subject to continued employment with Calix through the applicable vesting dates.

SEC source: 0001406666-25-000004 · wk-form4_1738703718.xml · derivative · entry 1

SINDELAR CORY · CIK 0001226868 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 107,775

Underlying: Common Stock · 107,775 shares

Expires 2034-02-08

F1 · derivative.exercise_date: On February 8, 2024, the reporting person was granted a performance-based stock option to purchase 225,000 shares of common stock. On January 31, 2025, the Talent and Compensation Committee (the Committee) of the Board of Directors of Calix, Inc. (Calix) determined that the performance criteria governing 47.9% of the grant had been achieved, resulting in 107,775 shares of common stock remaining subject to the option. The option vests: (i) as to 25% of the shares of common stock subject to the option, on February 8, 2025; and (ii) as to the remaining 75% of the shares of common stock subject to the option, quarterly in equal installments over 36 months from February 8, 2025, subject to continued employment with Calix through the applicable vesting dates.

SEC source: 0001406666-25-000002 · wk-form4_1738703524.xml · derivative · entry 3

Collins John Matthew · CIK 0001887165 · Chief Commercial Ops Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 195,000

Underlying: Common Stock · 195,000 shares

Expires 2035-01-31

F3 · derivative.exercise_date: The option vests: (i) as to 25% of the shares of common stock subject to the option, on January 31, 2026; and (ii) as to the remaining 75% of the shares of common stock subject to the option, quarterly in equal installments over 36 months from January 31, 2026, subject to continued employment with Calix through the applicable vesting dates.

SEC source: 0001406666-25-000002 · wk-form4_1738703524.xml · derivative · entry 2

Collins John Matthew · CIK 0001887165 · Chief Commercial Ops Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,850

Underlying: Common Stock · 68,850 shares

Expires 2034-02-08

F2 · derivative.exercise_date: On February 8, 2024, the reporting person was granted a performance-based option to purchase 75,000 shares of common stock. On January 31, 2025, the Committee determined that the performance criteria governing 91.8% of the grant had been achieved, resulting in 68,850 shares of common stock remaining subject to the option. The option vests: (i) as to 25% of the shares of common stock subject to the option, on February 8, 2025; and (ii) as to the remaining 75% of the shares of common stock subject to the option, quarterly in equal installments over 36 months from February 8, 2025, subject to continued employment with Calix through the applicable vesting dates.

SEC source: 0001406666-25-000002 · wk-form4_1738703524.xml · derivative · entry 1

Collins John Matthew · CIK 0001887165 · Chief Commercial Ops Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 107,775

Underlying: Common Stock · 107,775 shares

Expires 2034-02-08

F1 · derivative.exercise_date: On February 8, 2024, the reporting person was granted a performance-based stock option to purchase 225,000 shares of common stock. On January 31, 2025, the Talent and Compensation Committee (the Committee) of the Board of Directors of Calix, Inc. (Calix) determined that the performance criteria governing 47.9% of the grant had been achieved, resulting in 107,775 shares of common stock remaining subject to the option. The option vests: (i) as to 25% of the shares of common stock subject to the option, on February 8, 2025; and (ii) as to the remaining 75% of the shares of common stock subject to the option, quarterly in equal installments over 36 months from February 8, 2025, subject to continued employment with Calix through the applicable vesting dates.

SEC source: 0001406666-24-000040 · wk-form4_1730927923.xml · nonDerivative · entry 1

Russo Carl · CIK 0001483757 · Director · 10% owner

10b5-1 filing: Plan reported

Ownership: Indirect · See Footnote

Disclosed balance after: 2,189,188

F1 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $35.13 to $35.665, inclusive. Full information on the number of shares sold at each sale price is available upon request.

F2 · balance_after: In the Form 4 filed for the reporting person on August 5, 2024, 25,000 shares sold by The Crescentico Trust, Carl Russo, Trustee were mistakenly deducted from the direct holdings of the reporting person rather than from The Crescentico Trust, Carl Russo, Trustee. The shares held by the reporting person and The Crescentico Trust, Carl Russo, Trustee have been corrected in this Form 4.

F3 · ownership.nature: Shares held by The Crescentico Trust, Carl Russo, Trustee.

SEC source: 0001406666-24-000037 · wk-form4_1723752709.xml · nonDerivative · entry 1

Weening Michael · CIK 0001678385 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,463

F1 · shares: The reporting person is voluntarily reporting the acquisition of shares of the issuer's common stock pursuant to the Calix, Inc. Amended and Restated Employee Stock Purchase Plan ("ESPP") for the ESPP purchase period of February 15, 2024 through August 14, 2024. This transaction is exempt under Rule 16b-3(c).

F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on February 15, 2024, the first trading day of the purchase period.

SEC source: 0001406666-24-000036 · wk-form4_1723493952.xml · derivative · entry 1

Oosterman Wade · CIK 0001587270 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,317

Underlying: Common Stock · 7,317 shares

Expires 2034-08-08

F1 · derivative.exercise_date: The option vests and becomes exercisable with respect to 100% of the shares of common stock underlying the option on the earlier of (i) the one-year anniversary of the date of grant (August 8, 2025) or (ii) the day immediately preceding the date of the annual meeting of stockholders that occurs in the year following the year of grant.

SEC source: 0001406666-24-000031 · wk-form4_1722892131.xml · nonDerivative · entry 2

Russo Carl · CIK 0001483757 · Director · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,723,381

F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $38.1225 to $38.18, inclusive. Full information on the number of shares sold at each sale price is available upon request.

SEC source: 0001406666-24-000031 · wk-form4_1722892131.xml · nonDerivative · entry 1

Russo Carl · CIK 0001483757 · Director · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,724,661

F1 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $37.13 to $38.10, inclusive. Full information on the number of shares sold at each sale price is available upon request.

SEC source: 0001406666-24-000025 · wk-form4_1715637849.xml · derivative · entry 1

Russo Carl · CIK 0001483757 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,262

Underlying: Common Stock · 12,262 shares

Expires 2034-05-09

F1 · derivative.exercise_date: The option vests and becomes exercisable with respect to 100% of the shares of common stock underlying the option on the earlier of (i) the one-year anniversary of the date of grant (May 9, 2024) or (ii) the day immediately preceding the date of the annual meeting of stockholders that occurs in the year following the year of grant.

SEC source: 0001406666-24-000024 · wk-form4_1715637677.xml · derivative · entry 1

BOWICK CHRISTOPHER J · CIK 0001198471 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,262

Underlying: Common Stock · 12,262 shares

Expires 2034-05-09

F1 · derivative.exercise_date: The option vests and becomes exercisable with respect to 100% of the shares of common stock underlying the option on the earlier of (i) the one-year anniversary of the date of grant (May 9, 2024) or (ii) the day immediately preceding the date of the annual meeting of stockholders that occurs in the year following the year of grant.

SEC source: 0001406666-24-000023 · wk-form4_1715637568.xml · derivative · entry 1

CRUSCO KATHLEEN M · CIK 0001237508 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,262

Underlying: Common Stock · 12,262 shares

Expires 2034-05-09

F1 · derivative.exercise_date: The option vests and becomes exercisable with respect to 100% of the shares of common stock underlying the option on the earlier of (i) the one-year anniversary of the date of grant (May 9, 2024) or (ii) the day immediately preceding the date of the annual meeting of stockholders that occurs in the year following the year of grant.

SEC source: 0001406666-24-000022 · wk-form4_1715637480.xml · derivative · entry 1

Makagon Kira · CIK 0001586648 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,262

Underlying: Common Stock · 12,262 shares

Expires 2034-05-09

F1 · derivative.exercise_date: The option vests and becomes exercisable with respect to 100% of the shares of common stock underlying the option on the earlier of (i) the one-year anniversary of the date of grant (May 9, 2024) or (ii) the day immediately preceding the date of the annual meeting of stockholders that occurs in the year following the year of grant.

SEC source: 0001406666-24-000021 · wk-form4_1715637305.xml · derivative · entry 1

Mukherjee Rajatish · CIK 0001942773 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,262

Underlying: Common Stock · 12,262 shares

Expires 2034-05-09

F1 · derivative.exercise_date: The option vests and becomes exercisable with respect to 100% of the shares of common stock underlying the option on the earlier of (i) the one-year anniversary of the date of grant (May 9, 2024) or (ii) the day immediately preceding the date of the annual meeting of stockholders that occurs in the year following the year of grant.

SEC source: 0001406666-24-000020 · wk-form4_1715637185.xml · derivative · entry 1

Fields Eleanor · CIK 0001960298 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,262

Underlying: Common Stock · 12,262 shares

Expires 2034-05-09

F1 · derivative.exercise_date: The option vests and becomes exercisable with respect to 100% of the shares of common stock underlying the option on the earlier of (i) the one-year anniversary of the date of grant (May 9, 2024) or (ii) the day immediately preceding the date of the annual meeting of stockholders that occurs in the year following the year of grant.

SEC source: 0001406666-24-000019 · wk-form4_1715637005.xml · derivative · entry 1

Peters Kevin Robert · CIK 0001622622 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,262

Underlying: Common Stock · 12,262 shares

Expires 2034-05-09

F1 · derivative.exercise_date: The option vests and becomes exercisable with respect to 100% of the shares of common stock underlying the option on the earlier of (i) the one-year anniversary of the date of grant (May 9, 2024) or (ii) the day immediately preceding the date of the annual meeting of stockholders that occurs in the year following the year of grant.

SEC source: 0001406666-24-000008 · wk-form4_1708029134.xml · nonDerivative · entry 1

Weening Michael · CIK 0001678385 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,462

F1 · shares: The reporting person is voluntarily reporting the acquisition of shares of the issuer's common stock pursuant to the Calix, Inc. Amended and Restated Employee Stock Purchase Plan ("ESPP") for the ESPP purchase period of August 15, 2023 through February 14, 2024. This transaction is exempt under Rule 16b-3(c).

F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on February 14, 2024, the last trading day of the purchase period.

SEC source: 0001406666-24-000009 · wk-form4_1708029220.xml · nonDerivative · entry 1

SINDELAR CORY · CIK 0001226868 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,898

F1 · shares: The reporting person is voluntarily reporting the acquisition of shares of the issuer's common stock pursuant to the Calix, Inc. Amended and Restated Employee Stock Purchase Plan ("ESPP") for the ESPP purchase period of August 15, 2023 through February 14, 2024. This transaction is exempt under Rule 16b-3(c).

F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on February 14, 2024, the last trading day of the purchase period.

SEC source: 0001406666-24-000003 · wk-form4_1707779100.xml · derivative · entry 1

Eleniak Shane Todd Marshall · CIK 0001886143 · Chief Product Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 109,000

Underlying: Common Stock · 109,000 shares

Expires 2033-02-09

F1 · derivative.exercise_date: On February 9, 2023, the reporting person was awarded a performance-based nonqualified stock option grant covering 200,000 shares of common stock. On February 8, 2024, the Compensation Committee of Calix, Inc. determined that the performance criteria governing 54.5% of the grant had been achieved, resulting in a nonqualified stock option award of 109,000 shares of common stock for the reporting person. The nonqualified stock option award shall vest: (i) as to 25% of the shares of common stock subject to the stock option award, on February 8, 2024; and (ii) as to the remaining 75% of the shares of common stock subject to the stock option award, quarterly in equal installments over 36 months from February 8, 2024.

SEC source: 0001406666-24-000006 · wk-form4_1707779557.xml · derivative · entry 2

Weening Michael · CIK 0001678385 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,500

Underlying: Common Stock · 54,500 shares

Expires 2033-02-09

F3 · derivative.exercise_date: On February 9, 2023, the reporting person was awarded a performance-based nonqualified stock option grant covering 100,000 shares of common stock. On February 8, 2024, the Compensation Committee of Calix, Inc. determined that the performance criteria governing 54.5% of the grant had been achieved, resulting in a nonqualified stock option award of 54,500 shares of common stock for the reporting person. The nonqualified stock option award shall vest: (i) as to 25% of the shares of common stock subject to the stock option award, on February 8, 2024; and (ii) as to the remaining 75% of the shares of common stock subject to the stock option award, quarterly in equal installments over 36 months from February 8, 2024.